Description:
Entacapone is a selective and reversible inhibitor of the enzyme catechol-O-methyltransferase (COMT) (IC50 = 151 nM), commonly used in combination with other medications for the treatment of Parkinson's disease.
- Molecular Weight: 305.29
- Molecular Formula: C14H15N3O5
Purity: >98%
Canonical SMILES:
CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N
InChI:
InChI=1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+
InChIKey: JRURYQJSLYLRLN-BJMVGYQFSA-N
- Boiling Point: 526.6±50.0°C at 760 mmHg
- Melting Point: 162-163°C
- Solubility: Soluble in Chloroform (Slightly, Heated, Sonicated), Methanol (Slightly)
- Appearance: Yellow Solid
- Storage: Store at -20°C
Synonyms:
2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (2E)-; Comtan; HSDB 8251; HSDB-8251; HSDB8251; OR-611; OR 611; OR611; (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide; 2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-, (E)-; (E)-Entacapone; Comtess; Entacom; Parkicapone
More details are to be found on supplier website